Children receiving Heliox Inhalation in Croup: a randomised controlled trial

ISRCTN ISRCTN82240782
DOI https://doi.org/10.1186/ISRCTN82240782
Secondary identifying numbers N/A
Submission date
07/10/2006
Registration date
22/02/2007
Last edited
29/11/2012
Recruitment status
Stopped
Overall study status
Stopped
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Not provided at time of registration

Contact information

Prof Timothy Coats
Scientific

Emergency Department
Leicester Royal Infirmary
Infirmary Square
Leicester
LE1 5WW
United Kingdom

Email tc61@le.ac.uk

Study information

Study designRandomised double-blind controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study acronymCHIC
Study hypothesisWhat effect has Heliox on improving croup score and relieving symptoms in children with croup?
Ethics approval(s)Submitted to the University Hospitals of Leicester (UHL) R&D office and Ethics Committee [UHL 10193]
ConditionCroup (laryngotracheobronchitis)
InterventionPatients will be randomly allocated to receiving ,additionally to the standard croup treatment, either Heliox21 (study group) or Air (control group). Comparison will be made of the primary and secondary outcome measures, comparing all those allocated to Heliox versus those allocated to Air.

29/11/2012: Please note that this trial was never started due to a lack of funding.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Heliox21
Primary outcome measureModified Westley Croup Score at 30 minutes
Secondary outcome measures1. Croup score at 15 minutes
2. Respiratory rate at 15, 30 minutes
3. Parents assessment of change on Visual Analog Scale
4. Number of epinephrine nebulisers given
5. Requirement for supplemental oxygen therapy
6. Admission to hospital
7. Intubation rate
8. Length of stay in ED
9. Length of stay in hospital
10. Subsequent use of health services
Overall study start date01/03/2007
Overall study end date01/03/2010
Reason abandoned (if study stopped)Lack of funding/sponsorship

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit6 Months
Upper age limit5 Years
SexNot Specified
Target number of participants142
Participant inclusion criteriaChildren, aged six months to five years, presenting to the Emergency Department (ED) with moderate to severe croup (Modified Westley Croup Score of two or more).
Participant exclusion criteria1. Children whose oxygen saturation is less than 95%
2. Children with known pre-existing lung or airway disease, congenital heart disease, or features suggesting other causes of stridor, such as peritonsillar abscess, epiglottitis or inhaled foreign body
Recruitment start date01/03/2007
Recruitment end date01/03/2010

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Emergency Department
Leicester
LE1 5WW
United Kingdom

Sponsor information

University Hospitals of Leicester NHS Trust (UK)
University/education

Trust Headquarters
Gwendolen House
Gwendolen Road
Leicester
LE5 4QF
England
United Kingdom

Email djr8@le.ac.uk
Website http://www.uhl-tr.nhs.uk/
ROR logo "ROR" https://ror.org/02fha3693

Funders

Funder type

Not defined

Not provided at time of registration

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan